Division of Nano Life Science in the Graduate School of Frontier Science Initiative, WISE Program for Nano-Precision Medicine, Science and Technology, Kanazawa University, Kanazawa, Ishikawa 920-1192, ...

Robert Wickens has steadily worked his way back to winning form behind the wheel of a race car. It’s been a long road since his 2018 Indycar crash that took from him the use of his legs, but Wickens’ ...

Mila dressed up as a peacock for her first Halloween.

Bush Hager found love thanks to her father’s role as a head of state — she began dating husband Henry Hager in 2004 while he was working on George W.’s reelection campaign in 2004.

“Dosing the first patient in our global Phase 3 program is a major advancement as we work to deliver a differentiated, next-generation therapy for HCV,” said Jean-Pierre Sommadossi ...

The second phase of Mumbai Metro Line 3, also known as the Aqua Line, is nearing its launch. The Commissioner of Metro Rail Safety (CMRS) began inspecting the 9.77-km underground stretch from Bandra ...

Mumbai: The much-anticipated Phase 2 of Mumbai Metro Line 3 is nearing the finish line, with the 9.8-kilometre underground stretch from Bandra Kurla Complex (BKC) to Worli (Acharya Atre Chowk ...

(RTTNews) - Late-stage clinical biopharmaceutical company Sellas Life Sciences Group, Inc. (SLS) Tuesday announced positive survival in Cohort 3 data from the ongoing Phase 2 trial of SLS009 ...

Results from the HERCULES phase 3 study showed delay in disability progression in people living with non-relapsing secondary progressive multiple sclerosis Tolebrutinib has the potential to be the ...

Autoimmune generalized myasthenia gravis is a disease that manifests with fluctuating muscle weakness. Inebilizumab is a monoclonal antibody that depletes CD19+ B cells, which are central to ...

Throughout the course of multiple sclerosis, gradually progressive neurologic impairment can occur, which has been called disability accrual. Current disease-modifying therapies for multiple ...

Credit: Getty Images In a phase 3 clinical trial, researchers assessed the efficacy and safety of inebilizumab in patients with generalized myasthenia gravis. At Week 26, compared to the placebo ...